Shingrix Approved in the US for Prevention of Shingles in Immunocompromised Adults

Philadelphia, London -- 26 July 2021 -- GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news